Last reviewed · How we verify

NCT05893121: RESP-IRM

Evaluation of a Cardiac Coherence Session to Reducing Patients' Anxiety During a MRI Examination

Recruiting now Last updated 22 December 2025
What this trial tests

trial testing Cardiac coherence session in Anxiety in 60 participants. Currently enrolling.

Timeline
8 December 2023
Primary endpoint
30 March 2026
30 March 2026

Quick facts

Lead sponsorUniversity Hospital, Toulouse
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment60
Start date8 December 2023
Primary completion30 March 2026
Estimated completion30 March 2026
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Toulouse

Who can join

18 and older, any sex, with Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present project aims at conducting a proof of concept study to explore the pertinence of a single session of cardiac coherence, carried out in patients prior to an MRI examination and presenting anxiety in relation to this examination, to reduce their level of anxiety and thus improve the course of the examination.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Anxiety

Currently open trials in the same condition.

Other University Hospital, Toulouse trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05893121.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing